MENU
IBRX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
ImmunityBio (IBRX) Ownership - Who owns ImmunityBio?
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
3530 John Hopkins Court
Phone
+1 844 696-5235
Employees
628
Web
https://www.immunitybio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.4B
P/E Ratio
N/A
Total Cash
130.37M
Projected Growth
N/A
Total Debt
742.91M
Revenue
7.33M
Risk (Beta)
0.07
Dividend Yield
N/A
Total Cash/Share
0.18
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
IBRX
Capitalization
2.4B
P/E Ratio
N/A
Risk (Beta)
0.07
Dividend Yield
N/A
Total Cash
130M
Total Cash/Share
0.18
Total Debt
743M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
7.33M
ROE
N/A
Book Value
-745.15M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.9
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
70K
Current Ratio
2.68
Current Revenue Per Employee
9086.31
Dividends Per Share - Security
N/A
EBITDA
-421.03M
Float
N/A
Float - Current
N/A
Gross Income Margin
100.00
Revenue To Assets
-147.50
Shares Held By Institutions
389M
Shares Outstanding - Current
730M
Total Liabilities
1.11B
Total Volume MTD
N/A
Value
1
Gain YTD
28.516
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a producer of cancer treatment products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
3530 John Hopkins Court
Phone
+1 844 696-5235
Employees
628
Web
https://www.immunitybio.com